Shares of Xylem Inc. (NYSE:XYL) saw unusually-high trading volume on Monday . Approximately 996,860 shares traded hands during mid-day trading, an increase of 14% from the previous session’s volume of 871,838 shares.The stock last traded at $50.34 and had previously closed at $48.45.

XYL has been the subject of several recent research reports. Oppenheimer Holdings Inc. reissued an “outperform” rating on shares of Xylem in a research report on Tuesday, April 19th. Royal Bank Of Canada raised Xylem from a “sector perform” rating to an “outperform” rating and boosted their price target for the stock from $37.00 to $42.00 in a research report on Wednesday, June 1st. Barclays PLC upped their target price on Xylem from $39.00 to $45.00 and gave the company an “equal weight” rating in a research report on Monday, July 18th. Zacks Investment Research lowered Xylem from a “buy” rating to a “hold” rating in a research report on Friday, July 15th. Finally, Wedbush upped their target price on Xylem from $41.00 to $43.00 and gave the company a “neutral” rating in a research report on Wednesday, May 4th. Nine analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $42.25.

The company has a market cap of $9.02 billion and a PE ratio of 26.87. The company has a 50 day moving average price of $46.71 and a 200 day moving average price of $42.55.

Xylem (NYSE:XYL) last posted its earnings results on Tuesday, August 2nd. The company reported $0.48 EPS for the quarter, topping the Zacks’ consensus estimate of $0.47 by $0.01. The firm had revenue of $932 million for the quarter, compared to analyst estimates of $927.69 million. The firm’s revenue for the quarter was up 1.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.43 EPS. Analysts expect that Xylem Inc. will post $2.04 EPS for the current fiscal year.

In related news, Director Steven R. Loranger sold 32,246 shares of the business’s stock in a transaction dated Thursday, July 28th. The stock was sold at an average price of $48.01, for a total value of $1,548,130.46. Following the transaction, the director now owns 38,334 shares in the company, valued at approximately $1,840,415.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Steven R. Loranger sold 33,887 shares of the business’s stock in a transaction dated Thursday, August 11th. The shares were sold at an average price of $48.11, for a total value of $1,630,303.57. Following the completion of the transaction, the director now owns 11,243 shares in the company, valued at approximately $540,900.73. The disclosure for this sale can be found here.

A number of institutional investors recently modified their holdings of the stock. Utah Retirement Systems boosted its position in shares of Xylem by 0.3% in the fourth quarter. Utah Retirement Systems now owns 32,465 shares of the company’s stock valued at $1,185,000 after buying an additional 100 shares during the period. Aberdeen Asset Management PLC UK boosted its position in shares of Xylem by 24.9% in the fourth quarter. Aberdeen Asset Management PLC UK now owns 35,358 shares of the company’s stock valued at $1,259,000 after buying an additional 7,040 shares during the period. Comerica Bank boosted its position in shares of Xylem by 1.8% in the fourth quarter. Comerica Bank now owns 43,551 shares of the company’s stock valued at $1,497,000 after buying an additional 774 shares during the period. KBC Group NV boosted its position in shares of Xylem by 27.0% in the fourth quarter. KBC Group NV now owns 185,037 shares of the company’s stock valued at $6,754,000 after buying an additional 39,313 shares during the period. Finally, Morgan Stanley boosted its position in shares of Xylem by 2.3% in the fourth quarter. Morgan Stanley now owns 340,028 shares of the company’s stock valued at $12,411,000 after buying an additional 7,676 shares during the period.

Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.